Abbott Labs Files 2023 10-K, Details Fiscal Year Performance
Ticker: ABT · Form: 10-K · Filed: 2024-02-16T00:00:00.000Z
Sentiment: neutral
Topics: earnings, 10-K, pharmaceuticals
Related Tickers: ABT
TL;DR
**Abbott Labs just dropped its 2023 10-K, giving us the full financial picture for the year ending December 31st!**
AI Summary
Abbott Laboratories filed its 10-K on February 16, 2024, for the fiscal year ending December 31, 2023. The company, a pharmaceutical preparations firm (SIC 2834), is headquartered in Abbott Park, IL. This filing provides a comprehensive overview of its financial performance and operational status for the reported period.
Why It Matters
This filing offers investors and the public a detailed look into Abbott Laboratories' financial health and strategic direction, impacting investment decisions and market perception of the pharmaceutical giant.
Risk Assessment
Risk Level: medium — As a large pharmaceutical company, Abbott faces inherent risks related to R&D, regulatory approvals, and market competition, which are typically detailed in a 10-K.
Key Numbers
- 20231231 — Conformed Period of Report (The end date of the fiscal year covered by the 10-K filing.)
- 20240216 — Filed As Of Date (The date the 10-K filing was officially submitted to the SEC.)
- 118 — Public Document Count (The total number of public documents included in this submission.)
- 0000001800 — Central Index Key (CIK) (Unique identifier for ABBOTT LABORATORIES with the SEC.)
- 2834 — Standard Industrial Classification (SIC) (Industry code for Pharmaceutical Preparations, indicating Abbott's primary business.)
Key Players & Entities
- ABBOTT LABORATORIES (company) — Filer of the 10-K
- Abbott Park, IL (company) — Headquarters location
- December 31, 2023 (date) — Conformed period of report end date
- February 16, 2024 (date) — Filed as of date
- 0000001800 (company) — Central Index Key (CIK) for Abbott Laboratories
FAQ
What is the Central Index Key (CIK) for Abbott Laboratories?
The Central Index Key (CIK) for Abbott Laboratories is 0000001800.
When was Abbott Laboratories' 10-K filing submitted to the SEC?
Abbott Laboratories' 10-K filing was submitted to the SEC on February 16, 2024.
What is the fiscal year end date covered by this 10-K report?
The fiscal year end date covered by this 10-K report is December 31, 2023.
What is the Standard Industrial Classification (SIC) for Abbott Laboratories?
Abbott Laboratories' Standard Industrial Classification (SIC) is 2834, which corresponds to Pharmaceutical Preparations.
Where is Abbott Laboratories' business address located?
Abbott Laboratories' business address is 100 Abbott Park Road, Abbott Park, IL 60064-3500.
From the Filing
0001628280-24-005348.txt : 20240216 0001628280-24-005348.hdr.sgml : 20240216 20240216161558 ACCESSION NUMBER: 0001628280-24-005348 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 118 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 24648554 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 10-K 1 abt-20231231.htm 10-K abt-20231231 0000001800 2023 FY false P1M P2Y P8Y http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense 0.3333 http://fasb.org/us-gaap/2023#DeferredIncomeTaxesAndOtherAssetsNoncurrent http://fasb.org/us-gaap/2023#DeferredIncomeTaxesAndOtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent http://www.abbott.com/20231231#PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilities http://www.abbott.com/20231231#PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilities P12M http://fasb.org/us-gaap/2023#LongTermDebtNoncurrent http://fasb.org/us-gaap/2023#LongTermDebtNoncurrent 0000001800 2023-01-01 2023-12-31 0000001800 exch:XCHI 2023-01-01 2023-12-31 0000001800 exch:XNYS 2023-01-01 2023-12-31 0000001800 2023-06-30 iso4217:USD 0000001800 2024-01-31 xbrli:shares 0000001800 2022-01-01 2022-12-31 0000001800 2021-01-01 2021-12-31 iso4217:USD xbrli:shares 0000001800 2023-12-31 0000001800 2022-12-31 0000001800 2021-12-31 0000001800 2020-12-31 0000001800 us-gaap:CommonStockMember 2022-12-31 0000001800 us-gaap:CommonStockMember 2021-12-31 0000001800 us-gaap:CommonStockMember 2020-12-31 0000001800 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0000001800 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000001800 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000001800 us-gaap:CommonStockMember 2023-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2022-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2021-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2020-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2021-01-01 2021-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2023-12-31 0000001800 us-gaap:RetainedEarningsMember 2022-12-31 0000001800 us-gaap:RetainedEarningsMember 2021-12-31 0000001800 us-gaap:RetainedEarningsMember 2020-12-31 0000001800 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0000001800 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000001800 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000001800 us-gaap:RetainedEarningsMember 2023-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000001800 us-gaap:NoncontrollingInterestMember 2022-12-31 0000001800 u